HRL Hormel Foods (HRL) Insider Trading, Ownership & Congress Trades
Food & Beverage · Meat packing plants · CIK 0000048465
SEC filings
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
323
13F, latest reported quarter
What the filings say about HRL
Insiders, 180 days
-$294.2K net sold
1 buyer · 1 seller · 0% of sales under a 10b5-1 plan
Congress, 1 year
0 bought · 1 sold
Latest: sale, 2026-08-13
Hormel Foods insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, HORMEL FOODS CORP /DE/ insiders sold a net $294.2K of stock across 44 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 13.1% of the 76,375 shares held after it.
- No other insider bought within 30 days.
- 323 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Newlands William A bought about $201.0K of HRL on Oct 5, 2026, the largest insider purchase at the company on our record; 323 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 63.1% of the 32,002 shares held after it.
- No other insider sold within 30 days.
- 323 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Bhojwani Gary C. sold about $495.2K of HRL on Jul 8, 2026, the largest insider sale at the company since 2024; 323 funds added in the latest 13F quarter.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Mar 27, 2025.
- The trade is 16.3% of the 82,088 shares held after it.
- No other insider sold within 30 days.
- 323 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Murano Elsa A sold about $321.6K of HRL on Dec 11, 2025, the largest insider sale at the company since 2024; 323 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Apr 2, 2024.
- The trade is 4.7% of the 95,488 shares held after it.
- No other insider sold within 30 days.
- 323 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Murano Elsa A sold about $136.8K of HRL on Mar 27, 2025; 323 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Sep 27, 2024.
- The trade is 69.1% of the 7,100 shares held after it.
- No other insider bought within 30 days.
- 323 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: GROUP VICE PRESIDENT LYKKEN STEVEN J bought about $159.2K of HRL on Dec 6, 2024, the largest insider purchase at the company on our record; 323 funds added in the latest 13F quarter.44 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$294.2K over 180 days
+$201.0K over 90 days
below 55% of Food & Beverage
Congress
no House purchase disclosed in the last 12 months
Funds
323 funds bought in last quarter
more than 76% of Food & Beverage
Revenue
+1.6% year over year
below 59% of Food & Beverage
Margin
4.0% net margin
more than 55% of Food & Beverage
Buybacks
no share repurchases reported
Short interest
7.8% of the float short (float per yahoo 2026-10-26) · 4.7 days to cover · settled 2026-09-30
What changed in the last 30 days
Oct 6Director Newlands William A bought $201.0K (Oct 5)
Watch HRL
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-9.3%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns HRL: institutional holders (13F)
13F holdings, latest reported quarter
25,867,365 sh
$642.0M
19,705,555 sh
$489.1M
19,391,572 sh
$481.3M
15,171,561 sh
$376.6M
14,801,507 sh
$367.4M
Congress trades in HRL
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2026-08-13 · disclosed 19 days later
$1,001 - $15,000
Sold 2025-09-25 · disclosed 27 days later
$1,001 - $15,000
Bought 2025-09-11 · disclosed 41 days later
$1,001 - $15,000
Sold 2025-07-22 · disclosed 22 days later
$1,001 - $15,000
Bought 2025-07-16 · disclosed 28 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
HRL planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Gary C. Bhojwani
Filed 2026-07-08
$495.7K
HRL mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
VictoryShares Dividend Accelerator ETF
$8.4M position · as of 2026-06-30
3.4%
Invesco S&P 500 Equal Weight Consumer Staples ETF
$7.7M position · as of 2026-07-31
3.1%
Monarch Volume Factor Dividend Tree Index ETF
$2.5M position · as of 2026-05-31
2.3%
First Trust Nasdaq Food & Beverage ETF
$517.8K position · as of 2026-06-30
2.2%
Invesco High Yield Equity Dividend AchieversTM ETF
$23.2M position · as of 2026-07-31
2.1%
Invesco Bloomberg Pricing Power ETF
$3.5M position · as of 2026-05-31
2.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Government contracts
Award ceilings over the contract's life, subsidiaries included.
Not annual revenue (USASpending.gov).
Department Of Agriculture
COMMODITIES FOR USG FOOD DONATIONS: 2000011453/4100034865/TURKEY BREAST DELI SLICED FRZ PKG 8/5 LB,T · 2026-08-25
$6.2M
Federal awards ≥ $25M in the last 90 days, matched via the SAM.gov parent registry
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Hormel Foods Corporation Pac: Aka Hormel-Pac
Cycle 2026 · $0K spent
$0
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · James P.Snee
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$8.1M
$7.3M
$1.9M
-30%
+19%
2023
$6.8M
$457.8K
$1.6M
-32%
+5%
2022
$9.5M
$12.9M
$1.6M
-1%
+22%
2021
$10.0M
$6.5M
$2.1M
-13%
+4%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $294.2K sold by insiders over 180 days, 323 funds added last quarter. Each figure is a federal filing, dated the day it went public.
HRL financials
Revenue growth
+1.6%
XBRL, annual
Net margin
4.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$12.1B
four quarters, 2025-07-28 to 2026-07-26
Revenue, TTM HRL
| FY Oct 2025 | $12.1B |
| FY Oct 2024 | $11.9B |
| FY Oct 2023 | $12.1B |
| FY Oct 2022 | $12.5B |
| FY Oct 2021 | $11.4B |
| Jul 2026 | $3.0B |
| Apr 2026 | $3.0B |
| Jan 2026 | $3.0B |
| Oct 2025 | $3.2B |
| Jul 2025 | $3.0B |
| Apr 2025 | $2.9B |
| Jan 2025 | $3.0B |
| Oct 2024 | $3.1B |
At each fiscal year end
Single quarter
Net margin, TTM
+2.8%
net income over revenue, 2025-07-28 to 2026-07-26
Net margin, TTM HRL
| FY Oct 2025 | +4.0% |
| FY Oct 2024 | +6.8% |
| FY Oct 2023 | +6.6% |
| FY Oct 2022 | +8.0% |
| FY Oct 2021 | +8.0% |
| Jul 2026 | +2.0% |
| Apr 2026 | +5.3% |
| Jan 2026 | +6.0% |
| Oct 2025 | -1.8% |
| Jul 2025 | +6.1% |
| Apr 2025 | +6.2% |
| Jan 2025 | +5.7% |
| Oct 2024 | +7.0% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$780.9M
operating cash flow minus capex, 2025-07-28 to 2026-07-26
Free cash flow, TTM HRL
| FY Oct 2025 | $534.3M |
| FY Oct 2024 | $1.0B |
| FY Oct 2023 | $777.6M |
| FY Oct 2022 | $856.1M |
| FY Oct 2021 | $769.5M |
| Jul 2026 | $172.4M |
| Apr 2026 | $96.8M |
| Jan 2026 | $280.2M |
| Oct 2025 | $231.4M |
| Jul 2025 | $84.5M |
| Apr 2025 | -$18.6M |
| Jan 2025 | $237.0M |
| Oct 2024 | $324.8M |
At each fiscal year end
Single quarter
Debt to equity
0.36x
long-term 2026-07-26 plus current 2026-07-26; equity 2026-07-26
Debt to equity HRL
| FY Oct 2025 | 0.36x |
| FY Oct 2024 | 0.36x |
| FY Oct 2023 | 0.43x |
| FY Oct 2022 | 0.44x |
| FY Oct 2021 | 0.48x |
| Jul 2026 | 0.36x |
| Apr 2026 | 0.36x |
| Jan 2026 | 0.36x |
| Oct 2025 | 0.36x |
| Jul 2025 | 0.35x |
| Apr 2025 | 0.36x |
| Jan 2025 | 0.36x |
| Oct 2024 | 0.36x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.38x
TTM operating cash flow over long-term 2026-07-26 plus current 2026-07-26
Cash flow to debt HRL
| FY Oct 2025 | 0.30x |
| FY Oct 2024 | 0.44x |
| FY Oct 2023 | 0.32x |
| FY Oct 2022 | 0.34x |
| FY Oct 2021 | 0.30x |
| Jul 2026 | 0.38x |
| Apr 2026 | 0.35x |
| Jan 2026 | 0.31x |
| Oct 2025 | 0.30x |
| Jul 2025 | 0.33x |
| Apr 2025 | 0.35x |
| Jan 2025 | 0.41x |
| Oct 2024 | 0.44x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+4.3%
TTM net income over average of 2025-07-27 and 2026-07-26
Return on equity HRL
| FY Oct 2025 | +6.0% |
| FY Oct 2024 | +10.2% |
| FY Oct 2023 | +10.4% |
| FY Oct 2022 | +13.8% |
| FY Oct 2021 | +13.6% |
| Jul 2026 | +4.3% |
| Apr 2026 | +5.8% |
| Jan 2026 | +6.1% |
| Oct 2025 | +6.0% |
| Jul 2025 | +9.5% |
| Apr 2025 | +9.4% |
| Jan 2025 | +9.5% |
| Oct 2024 | +10.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.6%
TTM net income over average of 2025-07-27 and 2026-07-26
Return on assets HRL
| FY Oct 2025 | +3.6% |
| FY Oct 2024 | +6.0% |
| FY Oct 2023 | +5.9% |
| FY Oct 2022 | +7.7% |
| FY Oct 2021 | +8.0% |
| Jul 2026 | +2.6% |
| Apr 2026 | +3.5% |
| Jan 2026 | +3.7% |
| Oct 2025 | +3.6% |
| Jul 2025 | +5.7% |
| Apr 2025 | +5.4% |
| Jan 2025 | +5.6% |
| Oct 2024 | +6.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+3.7%
operating income after a 34.4% effective tax rate, over long-term 2026-07-26 plus current 2026-07-26 plus average of 2025-07-27 and 2026-07-26 minus cash
Return on invested capital HRL
| FY Oct 2025 | +5.1% |
| FY Oct 2024 | +8.3% |
| FY Oct 2023 | +8.3% |
| FY Oct 2022 | +10.5% |
| FY Oct 2021 | +10.2% |
| Jul 2026 | +3.7% |
| Apr 2026 | +5.0% |
| Jan 2026 | +5.3% |
| Oct 2025 | +5.1% |
| Jul 2025 | +7.7% |
| Apr 2025 | +8.1% |
| Jan 2025 | +8.0% |
| Oct 2024 | +8.3% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+4.9%
operating income (EBIT proxy) over average of 2025-07-27 and 2026-07-26 minus current liabilities
Return on capital employed HRL
| FY Oct 2025 | +6.0% |
| FY Oct 2024 | +9.2% |
| FY Oct 2023 | +9.3% |
| FY Oct 2022 | +11.4% |
| FY Oct 2021 | +11.4% |
| Jul 2026 | +4.9% |
| Apr 2026 | +5.9% |
| Jan 2026 | +6.1% |
| Oct 2025 | +6.0% |
| Jul 2025 | +8.4% |
| Apr 2025 | +8.4% |
| Jan 2025 | +8.7% |
| Oct 2024 | +9.2% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
33.43x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-28 to 2026-07-26
P/E, trailing HRL
| FY Oct 2025 | 27.39x |
| FY Oct 2024 | 21.27x |
| FY Oct 2023 | 21.50x |
| FY Oct 2022 | 25.66x |
| FY Oct 2021 | 25.49x |
| Jul 2026 | 40.17x |
| Apr 2026 | 25.35x |
| Jan 2026 | 27.64x |
| Oct 2025 | 27.39x |
| Jul 2025 | 21.34x |
| Apr 2025 | 21.84x |
| Jan 2025 | 22.54x |
| Oct 2024 | 21.27x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value HRL
| FY Oct 2025 | n/a |
| FY Oct 2024 | n/a |
| FY Oct 2023 | n/a |
| FY Oct 2022 | n/a |
| FY Oct 2021 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Oct 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield HRL
| FY Oct 2025 | n/a |
| FY Oct 2024 | n/a |
| FY Oct 2023 | n/a |
| FY Oct 2022 | n/a |
| FY Oct 2021 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Oct 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -54%, PEG needs growth
PEG, trailing HRL
| FY Oct 2025 | n/a |
| FY Oct 2024 | n/a |
| FY Oct 2023 | n/a |
| FY Oct 2022 | 2.51x |
| FY Oct 2021 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Oct 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-10 | 2024-10 | 2023-10 | 2022-10 | |
|---|---|---|---|---|
| Revenue | $12.1B | $11.9B | $12.1B | $12.5B |
| Gross profit | $1.9B | $2.0B | $2.0B | $2.2B |
| Operating income | $718.6M | $1.1B | $1.1B | $1.3B |
| Net income | $478.2M | $805.0M | $793.6M | $1.0B |
| EPS (diluted) | 0.87 | 1.47 | 1.45 | 1.82 |
| Operating cash flow | $845.3M | $1.3B | $1.0B | $1.1B |
| Cash | $670.7M | $741.9M | $736.5M | $982.1M |
| Long-term debt | $2.9B | $2.9B | $2.4B | $3.3B |
| Buybacks | $0 | $0 | $12.3M | $0 |
| Dividends paid | $633.2M | $615.0M | $592.9M | $557.8M |
SEC XBRL, fiscal years, as known on 2026-10-27
HRL Stock Sonar score 6/7 axes
Find similar shapesCompareHRL ranks highest on financial health (67th percentile) and profitability (42nd), and lowest on risk and compliance (11th), among Food & Beverage peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HRL filings, in plain words
Are Hormel Foods insiders buying or selling HRL?
In the 180 days to 2026-10-27, Hormel Foods insiders were net sellers, a net $294.2K: $201.0K of purchases and $495.2K of sales reported on Form 4, by 1 buyer and 1 seller.
Have members of Congress traded HRL?
Yes. In the year to 2026-10-27, 0 House members disclosed buying HRL and 1 House member disclosed selling it; the latest on record is a sale by Kevin Hern dated 2026-08-13.
Read the full summary
In the 180 days to 2026-10-27, Hormel Foods insiders were net sellers of HRL, a net $294.2K across purchases and sales reported on Form 4 by 1 buyer and 1 seller. In the year to 2026-10-27, 0 members of Congress disclosed buying HRL and 1 member disclosed selling it; the latest on record is a sale by Kevin Hern dated 2026-08-13. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
